Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

IOPtima Ltd.

Aug 2008
IOPtima Ltd. of Ramat Gan, Israel, has completed the three-month follow-up period for its initial human clinical study using the OT134 device. The laser-based therapy enables eye surgeons to operate and reduce internal eye pressure without penetrating the ocular membrane. So far, the results suggest that the laser filtration system may be a viable alternative to current glaucoma therapies.

BiophotonicsIOPtima Ltd.laser filtration systemlaser-based therapyNews & Featureslasers

Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,
x Subscribe to BioPhotonics magazine - FREE!